India to Canada: Metoclopramide Export Trade Route
India has recorded 31 verified shipments of Metoclopramide exported to Canada, representing a combined trade value of $1.6M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $50.9K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 44% of total export value with 8 shipments worth $689.4K USD. On the buying side, NA is the largest importer in Canada with $689.4K USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Canada Metoclopramide corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $1.6M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's metoclopramide manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $50.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with metoclopramide's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 31.2%, placing it at rank #11 among India's top metoclopramide export destinations globally.
On the import side, key buyers of Indian metoclopramide in Canada include NA, Marcan Pharmaceuticals Inc, , BAXTER CORPORATION CANADA and 8 others. NA is the single largest importer with 8 shipments valued at $689.4K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#11
- Annual growth+31.2%
- Demand growth+27.9%
- Regulatory ease76/100
Top 10 Indian Metoclopramide Exporters to Canada
Showing top 10 of 9 Indian suppliers exporting Metoclopramide to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED Avg $86.2K per shipment | 8 | $689.4K | 43.7% |
| 2 | IPCA LABORATORIES LIMITED Avg $169.7K per shipment | 3 | $509.0K | 32.3% |
| 3 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $28.0K per shipment | 8 | $224.3K | 14.2% |
| 4 | MAIVA PHARMA PRIVATE LIMITED Avg $62.3K per shipment | 2 | $124.6K | 7.9% |
| 5 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED Avg $25.4K per shipment | 1 | $25.4K | 1.6% |
| 6 | GRACURE PHARMACEUTICALS LIMITED Avg $2.3K per shipment | 2 | $4.6K | 0.3% |
| 7 | STERIL GENE LIFE SCIENCES PRIVATE LIMITED Avg $12 per shipment | 4 | $49 | 0.0% |
| 8 | RUCHA ENTERPRISES Avg $7 per shipment | 2 | $13 | 0.0% |
| 9 | 3CUBE MEDICARE PRIVATE LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 9 Indian companies exporting metoclopramide to Canada, ranked by total trade value. The listed exporters are: IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, MAIVA PHARMA PRIVATE LIMITED, STERIL-GENE LIFE SCIENCES PRIVATE LIMITED, GRACURE PHARMACEUTICALS LIMITED, STERIL GENE LIFE SCIENCES PRIVATE LIMITED, RUCHA ENTERPRISES, 3CUBE MEDICARE PRIVATE LIMITED . IPCA LABORATORIES LIMITED is the dominant supplier with 8 shipments worth $689.4K USD, giving it a 44% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Metoclopramide Importers in Canada
Showing top 10 of 11 known buyers in Canada receiving Metoclopramide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian metoclopramide in Canada include NA, Marcan Pharmaceuticals Inc, , BAXTER CORPORATION CANADA, Marcan Pharmaceuticals Inc. , DORVAL, among 11 total buyers. The largest importer is NA, accounting for $689.4K USD across 8 shipments — representing 44% of all metoclopramide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 8 | $689.4K | 43.7% |
| 2 | Marcan Pharmaceuticals Inc, | 2 | $298.8K | 18.9% |
| 3 | BAXTER CORPORATION CANADA | 8 | $224.3K | 14.2% |
| 4 | Marcan Pharmaceuticals Inc. | 1 | $210.1K | 13.3% |
| 5 | DORVAL | 2 | $124.6K | 7.9% |
| 6 | JAMP PHARMA CORPORATION. | 1 | $25.4K | 1.6% |
| 7 | PHARMARIS | 2 | $4.6K | 0.3% |
| 8 | KSENIIA EREMEEVA S OR LANDRY MBATKA | 4 | $49 | 0.0% |
| 9 | TO THE MASTER OF M.V. FEDERAL KIVA | 1 | $12 | 0.0% |
| 10 | TO THE MASTER OF M.V. FEDERAL ST L | 1 | $2 | 0.0% |
Showing top 10 of 11 Metoclopramide importers in Canada on this route.
Top 10 Metoclopramide Formulations Imported by Canada
Showing top 10 of 22 product formulations shipped on the India to Canada Metoclopramide route, ranked by trade value
Canada imports a wide range of metoclopramide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES MAR-METOCLOPRAMIDE — accounts for $298.8K USD across 2 shipments. There are 22 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES MAR-METOCLOPRAMIDE | 2 | $298.8K | 18.9% |
| 2 | HARMLESS MEDICINES : MAR-METOCLOPRAMIDE(Metoclopramide 5mg Tablets) (1x100s) (75810X1x100s PACK) UNIT RATE CA | 2 | $267.1K | 16.9% |
| 3 | HARMLESS MEDICINES:Metoclopramide 5mg Ta | 1 | $210.1K | 13.3% |
| 4 | HARMLESS MEDICINES : MAR-METOCLOPRAMIDE | 1 | $144.7K | 9.2% |
| 5 | HARMLESS MEDICINES MAR-METOCLOPRAMIDE(METOCLOPRAMIDE 5MG TABLETS) (1X100S) (71925X1X100S PACK) UNIT RATE CAD 2.62442 | 1 | $138.5K | 8.8% |
| 6 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION5MG/ML 2 ML GLASS VIAL | 1 | $92.0K | 5.8% |
| 7 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION5MG/ML 2 ML GLASS VIAL CA | 1 | $86.9K | 5.5% |
| 8 | HARMLESS MEDICINES - MAR-METOCLOPRAMIDE(METOCLOPRAMIDE 5MG TABLETS) (3633000 TBS) | 1 | $69.6K | 4.4% |
| 9 | HARMLESS MEDICINES - MAR-METOCLOPRAMIDE(Metoclopramide 5mg Tablets) (3633000 TBS)NOS | 3 | $69.4K | 4.4% |
| 10 | PMS-METOCLOPRAMIDE LNJ 5MG/ML(10X2ML/V)BATCH NO.:E044A010,MFG.DATE:01/2024,EXP.DATE :12/2026 | 1 | $62.7K | 4.0% |
Showing top 10 of 22 Metoclopramide formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 6 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's metoclopramide exports to Canada are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED — together account for 90% of total trade value on this route. The average shipment value of $50.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines : mar-metoclopramide(metoclopramide 5mg tablets) (1x100s) (75810x1x100s pack) unit rate ca and harmless medicines:metoclopramide 5mg ta , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 8 shipments worth $689.4K USD — representing 44% of all metoclopramide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.6M
- Avg. Shipment
- $50.9K
- Suppliers
- 9
- Buyers
- 11
- Transit (Sea)
- ~34 days
- Annual Growth
- +31.2%
Related Analysis
Other Metoclopramide Routes
Unlock the Full India to Canada Metoclopramide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 31 shipments on this route.
Frequently Asked Questions — India to Canada Metoclopramide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Metoclopramide to Canada?
The leading Indian exporters of Metoclopramide to Canada are IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED. IPCA LABORATORIES LIMITED holds the largest market share at approximately 44% of total trade value on this route.
Q What is the total value of Metoclopramide exports from India to Canada?
India exports Metoclopramide to Canada worth approximately $1.6M USD across 31 recorded shipments. The average value per shipment is $50.9K USD.
Q Which ports does India use to ship Metoclopramide to Canada?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 6 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Canada for Metoclopramide?
The average transit time for Metoclopramide shipments from India to Canada is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Canada Metoclopramide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.2% with demand growth tracking at 27.9%. The route is ranked #11 among India's top Metoclopramide export destinations globally.
Q How many suppliers are active on the India to Canada Metoclopramide route?
There are currently 9 active Indian suppliers exporting Metoclopramide to Canada. The market is moderately concentrated with IPCA LABORATORIES LIMITED accounting for 44% of total shipment value.
Q Who are the main importers of Metoclopramide from India in Canada?
The leading importers of Indian Metoclopramide in Canada include NA, Marcan Pharmaceuticals Inc, , BAXTER CORPORATION CANADA, Marcan Pharmaceuticals Inc. , DORVAL. NA is the largest buyer with 8 shipments worth $689.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Metoclopramide.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 11 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 31 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
31 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists